Testing effectiveness (Phase 2)Study completedNCT02545595
What this trial is testing
Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients
Who this might be right for
Morbid Obesity
Poitiers University Hospital